Anticoagulants, Thrombolytics, and Antiplatelet Agents
Listen now
Description
This week, Rob and Zach will be talking about Anticoagulants, Thrombolytics, and Antiplatelet Agents We will be discussing the following topics within this episode on Anticoagulants, Thrombolytics, and Antiplatelet Agents! Hemostasis: Coagulation Cascade, Extrinsic + Intrinsic PathwayAnticoagulants:HeparinUFHLMWHFondaparinux Direct Factor InhibitorsXa Inhibitors:RivaroxabanApixabanEdoxabanThrombin Inhibitors:DabigatranArgatrobanBivalirudinVitamin K Antagonists:Warfarin (Coumadin)Thrombolytics (tPA):AlteplaseReteplaseTenecteplaseStreptokinaseUrokinaseAntiplatelets:AspirinP2y12 Receptor Blockers:ClopidogrelTicagrelorPrasugrelTiclopidineGP2b/3a Inhibitors:AbciximabEptifibatideTirofibanPDE-3 Inhibitors:CilostazolAnticoagulants, Thrombolytics, Antiplatelet Agents MOATherapeutic IndicationsAdverse Drug Reactions (ADR's)Drug ComplicationsTo follow along with Notes & Illustrations for our podcasts please become a member on our website! https://www.ninjanerd.org/podcast/anticoagulants-thrombolytics-and-antiplatelet-agents Follow us on: YouTube: https://www.youtube.com/ninjanerdscienceInstagram: https://www.instagram.com/ninjanerdlecturesFacebook: https://www.facebook.com/NinjaNerdLecturesTwitter: https://twitter.com/ninjanerdsciDiscord: https://discord.com/invite/3srTG4dngWTikTok: https://www.tiktok.com/@ninjanerdlecturesSupport the show
More Episodes
Published 01/26/23
This week, Rob and Zach will be talking about Hyperaldosteronism. We will be discussing the following topics within this episode on Hyperaldosteronism! The Aldosterone Pathway and Normal PhysiologyAldosterone Target Organs & EffectsCauses of High AldosteroneDiagnostic WorkupTreatmentTo follow...
Published 01/26/23
This week, Rob and Zach will be talking about Cushing's Syndrome. We will be discussing the following topics within this episode on Cushing's Syndrome! The Cortisol Pathway and Normal PhysiologyCortisol Target Organs & EffectsCauses of High CortisolDiagnostic WorkupTreatmentTo follow along...
Published 01/19/23